SS-31 (Elamipretide) 10mg

SS-31 (Elamipretide) 10mg

€44,95
Skip to product information
SS-31 (Elamipretide) 10mg
  • SS-31 (Elamipretide) 10mg
  • SS-31 (Elamipretide) 10mg
SS-31 (Elamipretide) 10mg

SS-31 (Elamipretide) 10mg

€44,95

SS-31 (Elamipretide) is a small, cell-permeable tetrapeptide that selectively targets the inner mitochondrial membrane. Research focuses on its ability to optimize cellular energy production and reduce oxidative stress by binding directly to cardiolipin.

Specifications

Name SS-31 (Elamipretide)
Type Research Peptide: Mitochondrial Targeting Peptide
Number of Amino Acids 4 (Tetrapeptide)
Purity ± 99% (HPLC – COA Available)
Molecular Weight 639.80 g/mol
Analysis HPLC, MS
Form Lyophilized Powder
Storage Conditions 2-8°C (Short-term) or -20°C (Long-term)

Confidential Lab Data - Specification Sheet

Chemical Formula

C32H49N9O5

SS-31 Amino Acid Sequence (4 Amino Acids)
1D-Arg
2Dmt
3Lys
4Phe

Scientific Background

SS-31 (Elamipretide) belongs to the Szeto-Schiller (SS) peptide family. Developed specifically to penetrate cellular membranes without requiring specialized transporters, it targets mitochondrial microdomains to preserve bioenergetic efficiency under physiological stress.

Mechanism of Action

SS-31 associates directly with cardiolipin, an essential phospholipid in the inner mitochondrial membrane. By stabilizing cardiolipin structure, SS-31 helps maintain electron transport chain integrity, optimizes ATP synthesis, and prevents excessive reactive oxygen species (ROS) production.

For Research Purposes Only

This product is intended strictly for laboratory research.

By purchasing this product, you acknowledge these conditions and agree to follow established research protocols and safety practices.

USE & DISCLAIMER:

For research purposes only.
Not for human use, diagnosis or treatment.
For use only by qualified personnel in a controlled research environment.


By purchasing this product you confirm that you have read and understood these terms and conditions and that you have followed appropriate research practices.

You may also like